Overview
Location
United States, California, Pleasanton
Employees
51-200
Total raised
$16.53M
Founded date
2003
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 10, 2007 | Funding round | $7.53M |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 17, 2009 | USA, Juvaris BioTherapeutics Announces First Close on $25M Series B Financing | Juvaris BioTherapeutics, a Burlingame, CA.-based biotechnology company developing adjuvanted vaccines for infectious diseases, completed the first close on its $25m Series B equity financing. The round was led by SV Life Sciences with the p... |
| Nov 20, 2007 | Life sciences briefing: Tuesday, Nov. 20, 2007 | Featured companies: American TeleCare, Gliknik, Juvaris BioTherapeutics, Medsphere Systems, Primera Biosystems UPDATED: Expanded items on Juvaris, Medsphere, Primera, American TeleCare and Gliknik. Moved Broncus Tech and Aegerion Pharma ite... |
| Nov 2, 2007 | Life sciences briefing: Friday, Nov. 2, 2007 | Featured companies: Ascent Therapeutics, Bas Medical, Bikam Pharmaceuticals, Fundamental Applied Biology, Juvaris BioTherapeutics, Medavante, Trivitron, Vapotherm UPDATED: Expanded items on Bas Medical and Juvaris. Bas Medical raises $20M f... |
| Aug 2, 2007 | Juvaris Bio wins $9M grant for flu-vaccine adjuvants | Pleasanton, Calif.-based Juvaris BioTherapeutics, a four-year-old biotech developing vaccines and drugs against infectious disease, won a $9 million, five-year grant from the National Institute for Allergies and Infectious Disease. The mone... |
| Jan 10, 2007 | Influenza and pneumonia co., Juvaris, raises $6M from Kleiner | Juvaris BioTherapeutics, a Pleasanton, Calif. company developing vaccine products for influenza and pneumonia, said it has raised the first $6 million half of its first round of funding . The financing comes from Kleiner Perkins, the well-k... |
| Jan 5, 2007 | Cancer vaccine developer Juvaris raises $7.53M, led by Kleiner Perkins | Juvaris BioTherapeutics, a Pleasanton, Calif. developer of vaccines for cancer and infectious diseases, has raised $7.53 million in a first round of funding led by Kleiner Perkins Caufield & Byers, according to a regulatory filing cited... |
Reviews 0
FAQ about Juvaris BioTherapeutics
When was Juvaris BioTherapeutics founded?
Juvaris BioTherapeutics was founded in 2003.
How much funding has Juvaris BioTherapeutics raised?
Juvaris BioTherapeutics has raised $16.53M in total across 2 funding rounds.
What funding rounds has Juvaris BioTherapeutics raised?
Parsers VC lists 2 funding rounds of Juvaris BioTherapeutics, among them a funding round of $7.53M on Jan 10, 2007.
What has the press written about Juvaris BioTherapeutics?
Parsers VC has collected 7 articles mentioning Juvaris BioTherapeutics, among them “USA, Juvaris BioTherapeutics Announces First Close on $25M Series B Financing” (Sep 17, 2009) and “Life sciences briefing: Tuesday, Nov. 20, 2007” (Nov 20, 2007).
Is Juvaris BioTherapeutics still active?
Juvaris BioTherapeutics is probably closed: its latest activity on Parsers VC dates from Jan 27, 2010.